Diabetic mastopathy is a rare benign breast condition that develops in the setting of long-standing type 1 diabetes mellitus (rarely type 2). Histopathologically, it consists of dense lymphocytic infiltration (lobulitis and periductal B-lymphocyte infiltration), keloid-like fibrosis (thick, eosinophilic collagen bands), and epithelioid fibroblasts. Clinically, it presents as hard, painless, often bilateral palpable masses that can mimic malignancy on clinical examination. It is more common in premenopausal women, although cases have been reported in diabetic men. Its prevalence is estimated at 0.6-13% among women with type 1 diabetes. An autoimmune mechanism is thought to be involved; its association with thyroiditis and other autoimmune diseases supports this hypothesis.
Age Range
30-50
Peak Age
40
Gender
Female predominant
Prevalence
Rare
Although the pathogenesis of diabetic mastopathy is not fully elucidated, an autoimmune mechanism is strongly proposed. Prolonged hyperglycemia and accumulation of advanced glycation end products (AGEs) increase collagen cross-linking in the breast stroma and trigger keloid-like fibrosis formation. This abnormal collagen structure causes marked posterior acoustic shadowing on ultrasonography — sound waves are absorbed and scattered by the dense fibrous tissue, preventing visualization of structures behind it. Simultaneously, autoimmune B-lymphocyte infiltration concentrates in lobular and periductal areas (lobulitis); this lymphocytic infiltration can lead to contrast uptake on MRI because increased capillary permeability and neovascularization develop around activated lymphocytes. Keloid-like fibrosis appears as high density on mammography because dense collagen fibrils attenuate X-rays more than normal breast parenchyma. Histologically identified epithelioid fibroblasts are an indicator of myofibroblastic differentiation and contribute to stromal hardening. The combination of these pathological processes results in hard, irregular masses that mimic malignancy on both clinical examination and imaging.
Bilateral, hard, palpable, hypoechoic breast masses with marked posterior acoustic shadowing in a type 1 diabetes patient is the signature finding of diabetic mastopathy. This combination (clinical context + characteristic US appearance) is a reliable diagnostic clue to prevent unnecessary biopsies.
Irregularly or lobulated margined, markedly hypoechoic mass. The most striking feature is posterior acoustic shadowing that is disproportionately prominent relative to the mass size. The shadowing usually covers the entire posterior aspect and may extend into surrounding tissue. Mass margins may be poorly defined due to shadowing. This appearance strongly mimics invasive ductal carcinoma.
Report Sentence
An irregularly margined, markedly hypoechoic mass is seen in the breast parenchyma with disproportionately prominent posterior acoustic shadowing relative to the mass size; in the context of type 1 diabetes history, diabetic mastopathy should be the leading consideration.
Minimal or no vascularity is seen within the mass on Doppler ultrasonography. This finding is distinguishing from breast carcinomas where hypervascularity is frequently observed. Doppler signal is significantly reduced due to compression of vessels by dense fibrous tissue. Normal vascular flow is seen in surrounding breast tissue.
Report Sentence
No significant vascularity is seen within the mass on color Doppler examination; this finding, contrary to the hypervascularity expected in malignant lesions, is consistent with a benign fibrous process.
The most common mammographic finding is asymmetric parenchymal density; less frequently, an irregularly margined, high-density mass may be seen. Microcalcifications are typically absent — this is an important negative finding because calcifications frequently accompany DCIS and some invasive carcinomas. When bilateral involvement is present, symmetric or asymmetric density increases in both breasts are notable. Areas of keloid-like fibrosis can create architectural distortion.
Report Sentence
Asymmetric density increase / irregularly margined high-density mass is seen in the breast parenchyma on mammography without associated microcalcifications; in the context of type 1 diabetes history, this may be consistent with diabetic mastopathy.
Homogeneous or mildly heterogeneous low signal intensity on T2-weighted images. The high collagen content of keloid-like fibrosis shortens T2 relaxation time. This low T2 signal is different from the intermediate-to-high T2 signal demonstrated by many types of breast malignancies and is an important clue favoring a fibrosis-dominant process. Lesion margins may be better delineated on T2.
Report Sentence
The mass demonstrates homogeneous low signal intensity on T2-weighted sequences consistent with dense fibrous tissue content; this finding suggests a fibrous process rather than a cellular tumoral process.
The mass demonstrates minimal or mild progressive (Type I — slow rise) enhancement pattern on dynamic contrast-enhanced MRI. Early intense enhancement and late washout (Type III — washout) pattern is generally not seen. This differs from the rapid enhancement and washout pattern typically demonstrated by malignant lesions. Enhancement originates from the few capillary vessels within the fibrous tissue.
Report Sentence
On dynamic contrast-enhanced MRI, the mass demonstrates minimal, slowly progressive enhancement (Type I kinetics) without early enhancement or washout; this pattern does not favor malignancy and is consistent with a benign fibrous process.
Variable findings on diffusion-weighted imaging (DWI). Fibrous tissue generally does not show significant diffusion restriction (no low ADC); however, mild diffusion restriction may be seen in areas of dense lymphocytic infiltration. ADC values are typically higher than those of malignant lesions (markedly low ADC). This finding is explained by the low cellularity fibrous tissue not causing diffusion restriction.
Report Sentence
No significant diffusion restriction is seen in the mass on DWI and ADC values are preserved; this finding is consistent with a low-cellularity fibrous process rather than a highly cellular malignant process.
Criteria
Most common form. Long-standing type 1 diabetes (usually >10 years), insulin-dependent, frequently accompanied by micro/macrovascular complications. Bilateral involvement is common.
Distinct Features
More prominent keloid-like fibrosis, denser lymphocytic infiltration. Association with autoimmune thyroiditis is frequent. Recurrence is common (30-60% after excision).
Criteria
Rare form. Seen in type 2 diabetes patients, particularly those receiving insulin therapy. Presents at a later age compared to type 1.
Distinct Features
Less prominent lymphocytic infiltration, fibrosis-dominant. Unilateral involvement is more frequent. Autoimmune association is less prominent.
Criteria
Develops in the setting of other autoimmune diseases (Hashimoto thyroiditis, SLE, Sjogren) without diabetes. Histologically same triad (keloid-like fibrosis + lymphocytic lobulitis + epithelioid fibroblasts).
Distinct Features
Demonstrates imaging and histological findings identical to diabetic mastopathy. Lymphocytic lobulitis may be more prominent. The term 'lymphocytic mastopathy' encompasses this group as well.
Distinguishing Feature
Invasive ductal carcinoma shows Type III (washout) kinetic pattern, high DWI signal and low ADC on MRI, while diabetic mastopathy shows Type I (progressive) kinetics, low T2 signal and preserved ADC. Clinically, diabetes history is the critical distinguishing factor.
Distinguishing Feature
Invasive lobular carcinoma can also show shadowing on US and density increase on mammography. However, ILC demonstrates diffusion restriction (low ADC) and enhancement on MRI. ILC is usually unilateral, while diabetic mastopathy tends to be bilateral.
Distinguishing Feature
Granular cell tumor can also present as a hard hypoechoic mass with marked shadowing on US. However, it is usually solitary and unilateral with no diabetes association. Shows heterogeneous enhancement on MRI.
Distinguishing Feature
Fibroadenoma typically presents as an oval, well-circumscribed mass with posterior acoustic enhancement — no shadowing. Diabetic mastopathy shows irregular margins and marked shadowing. Fibroadenoma has a BI-RADS 2-3 appearance.
Urgency
routineManagement
conservativeBiopsy
NeededFollow-up
12-monthDiabetic mastopathy is a benign condition and does not require surgical excision. However, core biopsy is recommended at initial presentation to reliably exclude malignancy (BI-RADS 4). After histological diagnosis is established, follow-up is sufficient. If excision is performed, high recurrence rate (30-60%) is expected. Annual mammography and clinical examination follow-up is recommended. Malignancy risk is not increased.
Diabetic mastopathy is a benign condition requiring no treatment. Biopsy may be necessary as it can mimic carcinoma. Core biopsy may be technically difficult (firm tissue). Recurrence is common. Type 1 diabetes history is the key clinical information for diagnosis.